MedPacto, Inc. (KOSDAQ:235980)
South Korea
· Delayed Price · Currency is KRW 3,295.00
+5.00 (0.15%)
Apr 25, 2025, 10:40 AM KST
MedPacto Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -20,140 | -35,325 | -35,753 | -17,040 | -25,352 |
| Depreciation & Amortization | 1,542 | 1,833 | 1,866 | 1,723 | 1,437 |
| Loss (Gain) From Sale of Assets | - | 5.93 | - | - | - |
| Loss (Gain) From Sale of Investments | -554.71 | -350.51 | -1,018 | -627.44 | -2,213 |
| Loss (Gain) on Equity Investments | 452.51 | 390.44 | 525.38 | 361.1 | 248.59 |
| Stock-Based Compensation | 697.5 | 1,040 | 2,375 | 2,745 | 2,209 |
| Provision & Write-off of Bad Debts | -9.1 | -5.9 | - | - | - |
| Other Operating Activities | -222.6 | 6,305 | 141.08 | -11,453 | 114.38 |
| Change in Other Net Operating Assets | 1,676 | -193.16 | 2,249 | -861.82 | 174.88 |
| Operating Cash Flow | -16,559 | -26,301 | -29,614 | -25,153 | -23,382 |
| Capital Expenditures | -313.89 | -100.64 | -877.63 | -756.56 | -718.08 |
| Sale (Purchase) of Intangibles | -8.78 | -72.27 | -47.4 | -152.31 | -93.09 |
| Investment in Securities | -39,915 | 96,949 | 26,769 | -76,777 | 25,965 |
| Other Investing Activities | -0 | -249.88 | -80.91 | -80.24 | 975.46 |
| Investing Cash Flow | -40,237 | 96,526 | 25,763 | -77,766 | 26,129 |
| Short-Term Debt Issued | - | 1,000 | - | 35.49 | - |
| Long-Term Debt Issued | - | - | - | 70,000 | - |
| Total Debt Issued | - | 1,000 | - | 70,035 | - |
| Short-Term Debt Repaid | - | -1,000 | - | -35.49 | - |
| Long-Term Debt Repaid | -843.82 | -70,816 | -503.18 | -485.19 | -386 |
| Total Debt Repaid | -843.82 | -71,816 | -503.18 | -520.69 | -386 |
| Net Debt Issued (Repaid) | -843.82 | -70,816 | -503.18 | 69,515 | -386 |
| Issuance of Common Stock | - | 72,844 | 3,401 | 1,974 | 350.01 |
| Other Financing Activities | - | -15.02 | - | 34 | -24.41 |
| Financing Cash Flow | -843.82 | 2,014 | 2,898 | 101,523 | -60.4 |
| Foreign Exchange Rate Adjustments | 45.57 | 5.92 | 19.59 | -2.78 | -168.05 |
| Net Cash Flow | -57,595 | 72,244 | -933.04 | -1,399 | 2,519 |
| Free Cash Flow | -16,873 | -26,402 | -30,491 | -25,909 | -24,100 |
| Free Cash Flow Per Share | -501.02 | -1244.33 | -916.79 | -1265.52 | -1187.53 |
| Cash Interest Paid | - | 1,418 | - | - | - |
| Cash Income Tax Paid | 138.25 | -124.39 | 123.19 | 100.05 | 23.68 |
| Levered Free Cash Flow | -11,213 | -20,379 | -21,300 | -23,447 | - |
| Unlevered Free Cash Flow | -11,155 | -20,070 | -15,288 | -18,592 | - |
| Change in Net Working Capital | -1,329 | 4,018 | -6,017 | 2,028 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.